MATTHEW WINKLEMAN: Open Payments
NPI 1225018153 · HARRISBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 55 payments from 13 companies in 2025. Trend: 2023 $167 · 2024 $963 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $228 |
| AstraZeneca Pharmaceuticals LP | 12 | $195 |
| Lilly USA, LLC | 10 | $141 |
| Novo Nordisk Inc | 3 | $56 |
| Dexcom, Inc. | 2 | $52 |
| PFIZER INC. | 3 | $50 |
| Verona Pharma, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Lundbeck LLC | 1 | $20 |
Products named: VRAYLAR, MOUNJARO, BREZTRI, Dexcom G6 Transmitter, NURTEC ODT, AIRSUPRA, Ozempic, QULIPTA.
Industry payments across IL — which companies pay providers there.
